Abstract
Bariatric surgery for patients with severe obesity (body mass index (BMI) ≥ 50kg/m2) is technically challenging. Intragastric balloon (IGB) has been proposed for weight loss before bariatric surgery to reduce surgical risks but its efficacy remains unclear. We conducted a systematic review and meta-analysis of the effectiveness of IGB as bridging therapy and assess potential complications. Amongst 2419 citations, 13 studies were included. IGB resulted in a BMI reduction of 6.60 kg/m2 (MD=6.60, 95% CI: 5.06–8.15; I2=72%). The total post-procedural complication rate was 8.13% (95% CI: 4.04–13.17%), with majority being balloon intolerance. Overall, IGB is effective as a bridging therapy with adequate procedural safety profile, but further study is needed to evaluate the risk reduction for bariatric surgery and long-term weight-loss outcomes.
Graphical abstract
Similar content being viewed by others
Abbreviations
- IGB:
-
intragastric balloon
- BMI:
-
body mass index
- EWL:
-
excess weight loss
- RCT:
-
randomized controlled trial
- MD:
-
mean difference
- CI:
-
confidence interval
- SD:
-
standard deviation
References
Sturm R, Hattori A. Morbid obesity rates continue to rise rapidly in the United States. Int J Obes (Lond). 2013;37:889–91. https://doi.org/10.1038/ijo.2012.159.
Khaodhiar L, McCowen KC, Blackburn GL. Obesity and its comorbid conditions. Clin Cornerstone. 1999;2:17–31. https://doi.org/10.1016/s1098-3597(99)90002-9.
Arterburn DE, Maciejewski ML, Tsevat J. Impact of morbid obesity on medical expenditures in adults. Int J Obes (Lond). 2005;29:334–9. https://doi.org/10.1038/sj.ijo.0802896.
Engin A. The definition and prevalence of obesity and metabolic syndrome. Adv Exp Med Biol. 2017;960:1–17. https://doi.org/10.1007/978-3-319-48382-5_1.
Maciejewski ML, Arterburn DE, Van Scoyoc L, Smith VA, Yancy WS Jr, Weidenbacher HJ, et al. Bariatric surgery and long-term durability of weight loss. JAMA Surg. 2016;151:1046–55. https://doi.org/10.1001/jamasurg.2016.2317.
Sjöström L, Peltonen M, Jacobson P, Sjöström CD, Karason K, Wedel H, et al. Bariatric surgery and long-term cardiovascular events. JAMA. 2012;307:56–65. https://doi.org/10.1001/jama.2011.1914.
Schwartz ML, Drew RL, Chazin-Caldie M. Factors determining conversion from laparoscopic to open Roux-en-Y gastric bypass. Obes Surg. 2004;14:1193–7. https://doi.org/10.1381/0960892042386887.
Colles SL, Dixon JB, Marks P, Strauss BJ, O’Brien PE. Preoperative weight loss with a very-low-energy diet: quantitation of changes in liver and abdominal fat by serial imaging. Am J Clin Nutr. 2006;84:304–11. https://doi.org/10.1093/ajcn/84.1.304.
Ballantyne GH, Svahn J, Capella RF, Capella JF, Schmidt HJ, Wasielewski A, et al. Predictors of prolonged hospital stay following open and laparoscopic gastric bypass for morbid obesity: body mass index, length of surgery, sleep apnea, asthma, and the metabolic syndrome. Obes Surg. 2004;14:1042–50. https://doi.org/10.1381/0960892041975460.
Khan MA, Grinberg R, Johnson S, Afthinos JN, Gibbs KE. Perioperative risk factors for 30-day mortality after bariatric surgery: is functional status important? Surg Endosc. 2013;27:1772–7. https://doi.org/10.1007/s00464-012-2678-5.
Nickel F, de la Garza JR, Werthmann FS, Benner L, Tapking C, Karadza E, et al. Predictors of risk and success of obesity surgery. Obes Facts. 2019;12:427–39. https://doi.org/10.1159/000496939.
Still CD, Benotti P, Wood GC, Gerhard GS, Petrick A, Reed M, et al. Outcomes of preoperative weight loss in high-risk patients undergoing gastric bypass surgery. Arch Surg. 2007;142:994–8. https://doi.org/10.1001/archsurg.142.10.994.
Edholm D, Kullberg J, Haenni A, Karlsson FA, Ahlström A, Hedberg J, et al. Preoperative 4-week low-calorie diet reduces liver volume and intrahepatic fat, and facilitates laparoscopic gastric bypass in morbidly obese. Obes Surg. 2011;21:345–50. https://doi.org/10.1007/s11695-010-0337-2.
Huerta S, Li Z, Anthony T, Livingston EH. Feasibility of a supervised inpatient low-calorie diet program for massive weight loss prior to RYGB in superobese patients. Obes Surg. 2010;20:173–80. https://doi.org/10.1007/s11695-009-0001-x.
Rye P, Modi R, Cawsey S, Sharma AM. Efficacy of high-dose liraglutide as an adjunct for weight loss in patients with prior bariatric surgery. Obes Surg. 2018;28:3553–8. https://doi.org/10.1007/s11695-018-3393-7.
Regan JP, Inabnet WB, Gagner M, Pomp A. Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super obese patient. Obes Surg. 2003;13:861–4. https://doi.org/10.1381/096089203322618669.
Busetto L, Segato G, De Luca M, Bortolozzi E, MacCari T, Magon A, et al. Preoperative weight loss by intragastric balloon in super-obese patients treated with laparoscopic gastric banding: a case-control study. Obes Surg. 2004;14:671–6. https://doi.org/10.1381/096089204323093471.
Moura D, Oliveira J, De Moura EG, Bernardo W, Galvão Neto M, Campos J, et al. Effectiveness of intragastric balloon for obesity: a systematic review and meta-analysis based on randomized control trials. Surg Obes Relat Dis. 2016;12:420–9. https://doi.org/10.1016/j.soard.2015.10.077.
ASGE Bariatric Endoscopy Task Force and ASGE Technology Committee, Abu Dayyeh BK, Kumar N, Edmundowicz SA, Jonnalagadda S, Larsen M, Sullivan S, et al. ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointest Endosc. 2015;82:425-38.e5. https://doi.org/10.1016/j.gie.2015.03.1964.
Ashrafian H, Monnich M, Braby TS, Smellie J, Bonanomi G, Efthimiou E. Intragastric balloon outcomes in super-obesity: a 16-year city center hospital series. Surg Obes Relat Dis. 2018;14:1691–9. https://doi.org/10.1016/j.soard.2018.07.010.
Kim SH, Chun HJ, Choi HS, Kim ES, Keum B, Jeen YT. Current status of intragastric balloon for obesity treatment. World J Gastroenterol. 2016;22:5495–504. https://doi.org/10.3748/wjg.v22.i24.5495.
Majanovic SK, Ruzic A, Bulian AP, Licul V, Orlic ZC, Stimac D. Comparative study of intragastric balloon and cognitive-behavioral approach for non-morbid obesity. Hepatogastroenterology. 2014;61:937–41.
Borges AC, Almeida PC, Furlani SMT, Cury MS, Gaur S. Intragastric balloons in high-risk obese patients in a Brazilian center: initial experience. Rev Col Bras Cir. 2018;45:e1448. https://doi.org/10.1590/0100-6991e-20181448.
Göttig S, Daskalakis M, Weiner S, Weiner RA. Analysis of safety and efficacy of intragastric balloon in extremely obese patients. Obes Surg. 2009;19:677–83. https://doi.org/10.1007/s11695-009-9820-z.
Alfalah H, Philippe B, Ghazal F, Jany T, Arnalsteen L, Romon M, et al. Intragastric balloon for preoperative weight reduction in candidates for laparoscopic gastric bypass with massive obesity. Obes Surg. 2006;16:147–50. https://doi.org/10.1381/096089206775565104.
Coffin B, Maunoury V, Pattou F, Hébuterne X, Schneider S, Coupaye M, et al. Impact of intragastric balloon before laparoscopic gastric bypass on patients with super obesity: a randomized multicenter study. Obes Surg. 2017;27:902–9. https://doi.org/10.1007/s11695-016-2383-x.
Fernandes M, Atallah AN, Soares BG, Humberto S, Guimarães S, Matos D, Monteiro L, Richter B. Intragastric balloon for obesity. Cochrane Database Syst Rev. 2007;(1):CD004931. https://doi.org/10.1002/14651858.CD004931.pub2.
Patrzyk M, Sonke J, Glitsch A, Kessler R, Steveling A, Lünse S, et al. Gastric balloon implantation as part of morbid adiposity therapy changes the structure of the stomach wall. Visc Med. 2021. https://doi.org/10.1159/000514264.
Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135. https://doi.org/10.1186/1471-2288-14-135.
Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5:13. https://doi.org/10.1186/1471-2288-5-13.
Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60. https://doi.org/10.1136/bmj.327.7414.557.
Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. https://doi.org/10.1136/bmj.l4898.
Spyropoulos C, Katsakoulis E, Mead N, Vagenas K, Kalfarentzos F. Intragastric balloon for high-risk super-obese patients: a prospective analysis of efficacy. Surg Obes Relat Dis. 2007;3:78–83. https://doi.org/10.1016/j.soard.2006.11.001.
Khan O, Irukulla S, Sanmugalingam N, Vasilikostas G, Reddy M, Wan A. Simultaneous intra-gastric balloon removal and laparoscopic sleeve gastrectomy for the super-super obese patients–a prospective feasibility study. Obes Surg. 2013;23:585–7. https://doi.org/10.1007/s11695-013-0871-9.
Ball W, Raza SS, Loy J, Riera M, Pattar J, Adjepong S, et al. Effectiveness of intra-gastric balloon as a bridge to definitive surgery in the super obese. Obes Surg. 2019;29:1932–6. https://doi.org/10.1007/s11695-019-03794-8.
Leeman MF, Ward C, Duxbury M, de Beaux AC, Tulloh B. The intra-gastric balloon for pre-operative weight loss in bariatric surgery: is it worthwhile? Obes Surg. 2013;23:1262–5. https://doi.org/10.1007/s11695-013-0896-0.
Banks J, Abouelazayem M, Kaur V, Mcglone E, Fiorani C, Reddy M, et al. Routine intra-gastric balloon insertion in the management of ‘super-super-obese’ patients: an obituary? Obes Surg. 2021;31:2319–23. https://doi.org/10.1007/s11695-020-05102-1.
Weiner R, Gutberlet H, Bockhorn H. Preparation of extremely obese patients for laparoscopic gastric banding by gastric-balloon therapy. Obes Surg. 1999;9:261–4. https://doi.org/10.1381/096089299765553133.
Zerrweck C, Maunoury V, Caiazzo R, Branche J, Dezfoulian G, Bulois P, et al. Preoperative weight loss with intragastric balloon decreases the risk of significant adverse outcomes of laparoscopic gastric bypass in super-super obese patients. Obes Surg. 2012;22:777–82. https://doi.org/10.1007/s11695-011-0571-2.
Young JA, Alijani A, Patil PV, Shimi SM. Safety and feasibility of retrieval of intragastric balloon followed by antiobesity surgery on the same day. Surg Laparosc Endosc Percutan Tech. 2014;24:e137-9. https://doi.org/10.1097/SLE.0b013e3182901544.
Nguyen NT, Magno CP, Lane KT, Hinojosa MW, Lane JS. Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: findings from the National Health and Nutrition Examination Survey, 1999 to 2004. J Am Coll Surg. 2008;207:928–34. https://doi.org/10.1016/j.jamcollsurg.2008.08.022.
Pardina E, Onsurbe J, Carmano J, Jane D, Minaro A, Ferrer R. Morbid obesity and its comorbidities. Int Clin Pathol J. 2018;6:109–19. https://doi.org/10.15406/icpjl.2018.06.00169.
Sapala JA, Wood MH, Schuhknecht MP, Sapala MA. Fatal pulmonary embolism after bariatric operations for morbid obesity: a 24-year retrospective analysis. Obes Surg. 2003;13:819–25. https://doi.org/10.1381/096089203322618588.
Van Nieuwenhove Y, Dambrauskas Z, Campillo-Soto A, van Dielen F, Wiezer R, Janssen I, et al. Preoperative very low-calorie diet and operative outcome after laparoscopic gastric bypass: a randomized multicenter study. Arch Surg. 2011;146:1300–5. https://doi.org/10.1001/archsurg.2011.273.
Anderin C, Gustafsson UO, Heijbel N, Thorell A. Weight loss before bariatric surgery and postoperative complications: data from the Scandinavian Obesity Registry (SOReg). Ann Surg. 2015;261:909–13. https://doi.org/10.1097/SLA.0000000000000839.
Imaz I, Martínez-Cervell C, García-Alvarez EE, Sendra-Gutiérrez JM, González-Enríquez J. Safety and effectiveness of the intragastric balloon for obesity. A meta-analysis Obes Surg. 2008;18:841–6. https://doi.org/10.1007/s11695-007-9331-8.
Yorke E, Switzer NJ, Reso A, Shi X, de Gara C, Birch D, et al. Intragastric balloon for management of severe obesity: a systematic review. Obes Surg. 2016;26:2248–54. https://doi.org/10.1007/s11695-016-2307-9.
Kotzampassi K, Grosomanidis V, Papakostas P, Penna S, Eleftheriadis E. 500 intragastric balloons: what happens 5 years thereafter? Obes Surg. 2012;22:896–903. https://doi.org/10.1007/s11695-012-0607-2.
Angrisani L, Lorenzo M, Borrelli V, Giuffré M, Fonderico C, Capece G. Is bariatric surgery necessary after intragastric balloon treatment? Obes Surg. 2006;16:1135–7. https://doi.org/10.1381/096089206778392365.
Ochner CN, Dambkowski CL, Yeomans BL, Teixeira J, Xavier Pi-Sunyer F. Pre-bariatric surgery weight loss requirements and the effect of preoperative weight loss on postoperative outcome. Int J Obes (Lond). 2012;36:1380–7. https://doi.org/10.1038/ijo.2012.60.
Ienca R, Al Jarallah M, Caballero A, Giardiello C, Rosa M, Kolmer S, et al. The procedureless elipse gastric balloon program: multicenter experience in 1770 consecutive patients. Obes Surg. 2020;30:3354–62. https://doi.org/10.1007/s11695-020-04539-8.
Lee Y, Dang JT, Switzer N, Malhan R, Birch DW, Karmali S. Bridging interventions before bariatric surgery in patients with BMI ≥ 50 kg/m2: a systematic review and meta-analysis. Surg Endosc. 2019;33:3578–88. https://doi.org/10.1007/s00464-019-07027-y.
Périssé LG, Ecbc-Rj PC, Ribeiro KF. Gastric wall changes after intragastric balloon placement: a preliminary experience. Rev Col Bras Cir. 2016;43:286–8. https://doi.org/10.1590/0100-69912016004011 English, Portuguese.
van Wissen J, Bakker N, Doodeman HJ, Jansma EP, Bonjer HJ, Houdijk AP. Preoperative methods to reduce liver volume in bariatric surgery: a systematic review. Obes Surg. 2016;26:251–6. https://doi.org/10.1007/s11695-015-1769-5.
Guedes EP, Madeira E, Mafort TT, Madeira M, Moreira RO, Mendonça LM, et al. Impact of a 6-month treatment with intragastric balloon on body composition and psychopathological profile in obese individuals with metabolic syndrome. Diabetol Metab Syndr. 2016;8:81. https://doi.org/10.1186/s13098-016-0197-6.
Jamal MH, Almutairi R, Elabd R, AlSabah SK, Alqattan H, Altaweel T. The safety and efficacy of procedureless gastric balloon: a study examining the effect of elipse intragastric balloon safety, short and medium term effects on weight loss with 1-year follow-up post-removal. Obes Surg. 2019;29:1236–41. https://doi.org/10.1007/s11695-018-03671-w.
De Peppo F, Caccamo R, Adorisio O, Ceriati E, Marchetti P, Contursi A, et al. The Obalon swallowable intragastric balloon in pediatric and adolescent morbid obesity. Endosc Int Open. 2017;5:E59–63. https://doi.org/10.1055/s-0042-120413.
Layec S, Val-Laillet D, Heresbach D, Malbert CH. Gastric tone, volume and emptying after implantation of an intragastric balloon for weight control. Neurogastroenterol Motil. 2010;22:1016–21. https://doi.org/10.1111/j.1365-2982.2010.01525.x.
Joffe OY, Molnar IM, Tarasyuk TV, Tsyura YP, Stetsenko OP, Kryvopustov MS. Morphological changes of gastric mucosa after insertion of intragastric balloon. Klin Khir. 2015;10:70–2. Ukrainian.
Dogan UB, Gumurdulu Y, Akin MS, Yalaki S. Five percent weight lost in the first month of intragastric balloon treatment may be a predictor for long-term weight maintenance. Obes Surg. 2013;23:892–6. https://doi.org/10.1007/s11695-013-0876-4.
Kotinda APST, de Moura DTH, Ribeiro IB, Singh S, da Ponte Neto AM, Proença IM, et al. Efficacy of intragastric balloons for weight loss in overweight and obese adults: a systematic review and meta-analysis of randomized controlled trials. Obes Surg. 2020;30:2743–53. https://doi.org/10.1007/s11695-020-04558-5.
Acknowledgements
We would like to thank Nay Lin Han for his assistance with the data analysis.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
This article does not contain any studies with human participants or animals performed by any of the authors. Informed consent does not apply.
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Key points
• Intragastric balloon results in a substantial BMI reduction of 6.60 kg/m2 before bariatric surgery.
• The total post-procedural complication rate from intragastric balloon was 8.13%, with majority being balloon intolerance.
• Compared with other bridging therapies/no bridging, IGB achieved superior weight loss but its effect on post-bariatric surgery complications requires further study.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Loo, J.H., Lim, Y.H., Seah, H.L. et al. Intragastric Balloon as Bridging Therapy Prior to Bariatric Surgery for Patients with Severe Obesity (BMI ≥ 50 kg/m2): a Systematic Review and Meta-analysis. OBES SURG 32, 489–502 (2022). https://doi.org/10.1007/s11695-021-05772-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-021-05772-5